Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
As of close of business last night, Aldeyra Therapeutics Inc’s stock clocked out at $6.92, up 4.53% from its previous closing price of $6.62. In other words, the price has increased by $4.53 from its previous closing price. On the day, 0.64 million shares were traded.
Ratios:
To gain a deeper understanding of ALDX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.48 and its Current Ratio is at 5.48. In the meantime, Its Debt-to-Equity ratio is 0.22 whereas as Long-Term Debt/Eq ratio is at 0.21.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 12 ’24 when Machatha Stephen sold 16,041 shares for $4.74 per share. The transaction valued at 75,975 led to the insider holds 236,771 shares of the business.
Greenberg Bruce sold 10,834 shares of ALDX for $51,313 on Aug 12 ’24. The insider now owns 126,382 shares after completing the transaction at $4.74 per share. On Aug 12 ’24, another insider, Greenberg Bruce, who serves as the Officer of the company, bought 10,834 shares for $5.10 each.
Stock Price History:
Over the past 52 weeks, ALDX has reached a high of $6.92, while it has fallen to a 52-week low of $2.71. The 50-Day Moving Average of the stock is 22.35%, while the 200-Day Moving Average is calculated to be 39.48%.
Shares Statistics:
A total of 59.65M shares are outstanding, with a floating share count of 57.98M. Insiders hold about 2.90% of the company’s shares, while institutions hold 62.59% stake in the company.
